Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects

Endocrine Reviews

Volumn 19, Issue 4, 1998, Pages 477-490

  Ferrannini, Ele ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

DISEASE COURSE; GENETIC ANALYSIS; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN METABOLISM; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0032456709     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.19.4.0336     Document Type: Review

References (160)

1. DeFronzo RA 1988 The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
2. Kahn CR 1994 Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084
3. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37:1595-1607
4. World Health Organization 1985 Diabetes mellitus: report of a WHO Study Group. Technical Report Series 727. World Health Organization, Geneva
5. Zimmet PZ 1995 The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care 18: 1050-1064
6. Harris MI, Zimmet P 1997 Classification of diabetes mellitus and other categories of glucose intolerance. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (Honorary) (eds) International Textbook of Diabetes Mellitus. ed. 2. John Wiley & Sons Ltd, Chichester, U.K., vol 1:9-23
7. Taylor SI, Accili D, Imai Y 1994 Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43:735-740
8. Thow J, Samad A, Alberti KGMM 1988 Epidemiology and general aspects of diabetes secondary to pancreatopathy. In: Tiengo A, Alberti KGMM, Del Prato S, Vranic M (eds) Diabetes Secondary to Pancreatopathy. Excerpta Medica ICS 762, Amsterdam, pp 7-20
9. DeFronzo RA, Binder C, Wahren J, Felig P, Ferrannini E, Faber O 1981 Sensitivity of insulin secretion to feedback inhibition by hyperinsulinemia. Acta Endocrinol (Copenh) 98:81-84
10. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA 1994 Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 37:1025-1035
11. Unger RH, Grundy S 1985 Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119-125
12. Yki-Järvinen H 1992 Glucose toxicity. Endocr Rev 13:415-431
13. Weir GC 1982 Non-insulin-dependent diabetes mellitus: interplay between β-cell inadequacy and insulin resistance. Am J Med 73: 461-464
14. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkänen L, Karter AJ, Hamman R, Saad MF 1997 Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM. The Insulin Resistance Atherosclerosis Study. Diabetes 46:63-69
15. Arner P, Pollare T, Lithell H 1991 Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and nonobese subjects. Diabetologia 34:483-487
16. Banerji MA, Chaiken RL, Gordon D, Krai JG, Lebovitz HE 1995 Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 44:141-146
17. Groop L, Ekstrand A, Forsblom C, Widén E, Groop P-H, Teppo A-M, Eriksson J 1993 Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:642-647
18. de Courten M, Bennett PH, Tuomilehto J, Zimmet P 1995 Epidemiology of NIDDM in non-Europids. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (Honorary) (eds) International Textbook of Diabetes Mellitus. ed. 2. John Wiley & Sons Ltd, Chichester, U.K., vol 1:143-170
19. Del Prato S, Ferrannini E, DeFronzo RA 1986 Evaluation of insulin sensitivity in man In: Clarke WL, Larner J, Pohl SL (eds) Methods in Diabetes Research. Clinical Methods. John Wiley & Sons, New York, vol 2:35-76
20. Rizza RA, Mandarino LJ, Gerich JE 1981 Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240:E630-E639
21. DeFronzo RA, Ferrannini E 1982 Influence of plasma glucose and insulin concentration on plasma glucose clearance in man. Diabetes 31:683-688
22. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C 1993 Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988-1992
23. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U 1996 Insulin action and age. Diabetes 45:947-953
24. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O 1996 Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195-1209
25. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman P 1996 Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817
26. Kahn SE, McCulloch DK, Porte Jr D 1997 Insulin secretion in the normal and diabetic human. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (Honorary) (eds) International Textbook of Diabetes Mellitus, ed. 2. John Wiley & Sons Ltd, Chichester, U.K., vol 1:337-353
27. Ferrannini E, Pilo A 1979 Pattern of insulin delivery after intravenous glucose injection, and its relation to plasma glucose disappearance. J Clin Invest 64:243-249
28. O'Meara NM, Sturis J, Van Cauter E, Polonsky KS 1993 Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest 92:262-271
29. Jaspan JB, Lever E, Polonsky KS, Van Cauter E 1986 In vivo pulsatility of pancreatic islet peptides. Am J Physiol 251:E215-E226
30. Robbins DC, Jaspan J, Vasquez B, Van Cauter E 1987 Biphasic patterns of peripheral insulin and glucose levels following lunch in normal subjects. Diabetes Care 10:293-299
31. Polonsky KS, Given BD, Van Cauter E 1988 Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81:442-448
32. Cerasi E, Luft R 1967 The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol (Copenh) 55:278-304
33. Efendic S, Grill V, Luft R, Wajngot A 1988 Low insulin response: a marker of pre-diabetes. Adv Exp Med Biol 246:167-174
34. Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW 1988 Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 37:736-744
35. Martin BC, Warram JH, Rosner B, Rich SS, Soeldner JS, Krolewski AS 1992 Familial clustering of insulin sensitivity. Diabetes 41:850-856
36. Haffner SM, Stern M, Hazuda H, Pugh J, Patterson J 1986 Hyperinsulinemia in a population at high risk for noninsulin-dependent diabetes. N Engl J Med 315:220-224
37. Sicree RA, Zimmet PZ, King HOM, Coventry JS 1987 Plasma insulin among Nauruans: prediction of deterioration in glucose tolerance over 6 years. Diabetes 36:179-186
38. Charles M, Fontbonne A, Thibilt N, Warnet J, Rosselin G, Eschwege E 1991 Risk factors for NIDDM in a white population: Paris prospective study. Diabetes 40:796-799
39. Kolterman O, Insel J, Saekow M, Olefsky J 1980 Mechanism of insulin resistance in obesity. Evidence for receptor and post-receptor defect. J Clin Invest 65:1272-1284
40. Kissebah AH 1991 Insulin resistance in visceral obesity. Int J Obesity 15[Suppl 2]:109-115
41. Rosenthal M, Haskel HL, Solomon R, Widstrom A, Reaven GM 1983 Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes 32:408-411
42. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H 1997 Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. Hypertension 30:1144-1149
43. Vaag A, Henriksen J, Beck-Nielsen H 1992 Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Invest 89:782-788
44. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, Heynen G 1991 Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 91:589-595
45. Facchini F, Hollenbeck CB, Jeppesen J, Chen Y-DI, Reaven GM 1992 Insulin resistance and cigarette smoking. Lancet 339:1128-1130
46. Paolisso G, Gambardella A, Galzerano D, D'Amore A, Balbi V, Varricchio M, D'Onofrio F 1993 Metabolic features of patients with and without coronary heart disease but with superimposable cluster of cardiovascular risk factors. Coron Artery Dis 4:1085-91
47. Bressler P, Bailey SR, Matsuda M, DeFronzo RA 1996 Insulin resistance and coronary artery disease. Diabetologia 39:1345-1350
48. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Järvinen H, Evron W, Dailey G, Gerich J 1995 Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 273:1855-1861
49. Rewers M, Hamman RF 1995 Risk factors for non-insulin-depedent diabetes. In: Diabetes in America, ed. 2. NIH Publication No. 95-1468. National Institutes of Health, Bethesda, MD, pp 179-220
50. Bogardus C, Lillioja S, Howard BV, Reaven GM, Mott D 1984 Relationship between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238-1246
51. Reaven GM, Hollenbeck CB, Chen Y-DI 1989 Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55
52. Polonsky KS 1995 The β-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705-717
53. Haffner SM, Miettinen H, Gaskill SP, Stern MP 1996 Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39:1201-1207
54. Vaag A, Henriksen J, Madsbad S, Holm N, Beck-Nielsen H 1995 Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690-698
55. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schalin C, Groop L 1989 Early metabolic defects in persons at increased risk for noninsulin-dependent diabetes mellitus. N Engl J Med 318:337-343
56. Gulli G, Ferrannini E, Stern MP, Haffner SM, DeFronzo RA 1992 The metabolic profile of NIDDM is fully established in glucosetolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575-1586
57. Vaag A, Henriksen JE, Beck-Nielsen H 1992 Decreased insulin activation of glycogen synthase in skeletal muscles of young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788
58. Handberg A, Vaag A, Vinten J 1993 Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first-degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:668-674
59. Matsuda A, Kuzuya T 1996 The prevalence of low insulin responders to oral glucose among groups with various patterns of family history of diabetes. Diabet Med 13:S59-S62
60. O'Rahilly S, Turner R, Matthews D 1988 Impaired pulsatile secretion of insulin in relatives of patients with noninsulin-dependent diabetes. N Engl J Med 318:1225-1230
61. Gerich JE 1998 The genetic basis of non-insulin-dependent diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491-503
62. Vaag A, Groop L, Thye-Rönn P, Lehtovirta M 1997 Metabolic impact of family history of NIDDM. Diabetologia 40[Suppl 1]:A4 (Abstract)
63. Perseghin G, Ghosh S, Gerow K, Shulman GI 1997 Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009
64. Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M 1997 Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 100: 86-96
65. Buchanan T, Catalano P 1995 The pathogenesis of GDM: implications for diabetes after pregnancy. Diabetes Rev 3:584-601
66. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR 1990 Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-914
67. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK 1990 Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-290
68. Florey CV, Uppal S, Lowy C 1976 Relation between blood pressure, weight, and plasma sugar and serum insulin levels in school-children aged 9-12 years in Westland, Holland. Br Med J 1:1368-1372
69. Miles PDG, Li S, Hart M, Romeo O, Cheng J, Cohen A, Raafat K, Moossa AR, Olefsky JM 1998 Mechanisms of insulin resistance in experimental hyperinsulinemic dogs. J Clin Invest 101:202-211
70. Saad M, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH 1988 The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1509
71. Cerasi E 1995 Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? Diabetologia 38:992-997
72. Efendic S, Cerasi E, Luft R, Gladnikoff G 1976 Potentiation of glucose-induced insulin release by glucose in the isolated pancreas of fed and fasted rats. Diabetes 25:949-957
73. Porte JrD, Woods SC 1990 Neural regulation of islet hormones and its role in energy balance and stress hyperglycemia. In: Rifkin H, Porte Jr D (eds) Diabetes Mellitus: Theory and Practice. Elsevier, New York, pp 175-197
74. Ebert R, Creuzfeld W 1987 Gastrointestinal peptides and insulin secretion. Diabetes Metab Rev 3:1-6
75. Leahy JL 1996 Detrimental effects of chronic hyperglycemia on the pancreatic β-cell. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes Mellitus. A Fundamental and Clinical Text. Lippincott-Raven Publishers, Philadelphia, pp 103-113
76. Flakoll P, Carlson MG, Cherrington AD 1996 Physiologic action of insulin. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes Mellitus. A Fundamental and Clinical Text. Lippincott-Raven Publishers, Philadelphia, pp 121-132
77. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G 1997 Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166-1173
78. Perry IJ, Wannamethee SG, Walker MK, Thompson AG, Whincup PH, Shaper GA 1995 Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. Br Med J 310:560-564
79. Modan M, Karasik A, Halkin H 1986 Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non insulin dependent) diabetes and on insulin response; the Israeli study of glucose intolerance, obesity and hypertension. Diabetologia 29:82-89
80. Felber JP, Golay A, Jéquier E, Curchod B, Temler E, DeFronzo RA, Ferrannini E 1988 The metabolic consequences of long-term human obesity. Int J Obes Relat Metab Disord 12:377-385
81. Randle PJ, Garland PB, Hales CN, Newsholme EA 1963 The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789
82. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI 1996 Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865
83. Felber J-P, Ferrannini E, Golay A, Meyer HU, Thiebaud D, Curchod B, Maeder E, Jequiér E, DeFronzo RA 1987 Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350
84. Chert Y-DI, Golay A, Swilocki ALM, Reaven GM 1987 Resistance to insulin suppression of plasma free fatty acid concentration and insulin stimulation of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64:7-21
85. Ferrannini E, Camastra S, Coppack SW, Fliser D, Golay A, Mitrakou A 1997 Insulin action and non-esterified fatty acids. Proc Nutr Soc 56:753-761
86. Phillips DIW, Caddy S, Illic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R 1996 Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45:947-950
87. Pan DA, Lillioja S, Kriketos AD Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH 1997 Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988
88. Bjorkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LB 1993 The relationship between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 328:238-244
89. Eriksson K-F, Laurila E, Kiens B, Groop L 1997 Skeletal muscle triglycerides in impaired glucose tolerance and NIDDM. Diabetologia 40[Suppl 1]:A286 (Abstract)
90. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA 1983 Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747
91. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen M-R, Groop LC 1991 Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:409-415
92. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E 1995 A high concentration of fasting non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213-1217
93. Charles MA, Eschwège E, Thibult N, Claude J-R, Warnet J-M, Rosselin GE, Girard J, Balkau B 1997 The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 40: 1101-1106
94. Sako Y, Grill V 1990 A 48-h lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580-1589
95. Zhou YP, Grill V 1994 Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876
96. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F 1995 Opposite effects of short-and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295-1299
97. Rich SS 1990 Mapping genes in diabetes: genetic epidemiological perspective. Diabetes 39:1315-1319
98. Rich SS 1995 Positional cloning works! Identification of genes that cause IDDM. Diabetes 44:139-140
99. Hanis CL 1997 Power considerations in the genetics of diabetes and other common chronic conditions. Diabetes Rev 5:270-276
100. Bell GI, Cox NJ, Lindner T, Concannon P, Spielman RS, Boerwinkle E, Hanis CL 1997 Genetics of NIDDM in the Mexican-Americans of Starr County, Texas: an update. Diabetes Rev 5:277-291
101. Ghosh S, Schork NJ 1996 Genetic analysis of NIDDM. The study of quantitative traits. Diabetes 45:1-14
102. Schumacher MC, Hasstedt SJ, Hunt SC, Williams RR, Elbein SC 1992 Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 41:416-423
103. Mitchell BD, Kammerer CM, Hixson JI, Atwood LD, Hackleman S, Blangero J, Haffner SM, Stern MP, MacCluer JW 1995 Evidence for a major gene affecting postchallenge insulin levels in Mexican Americans. Diabetes 44:284-289
104. Clark PM, Levy JC, Cox L, Burnett M, Turner RC, Hales CN 1992 Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type II (non-insulin-dependent) diabetic subjects. Diabetologia 35: 469-474
105. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Schneider AE, Hales CN, Yudkin JS 1990 The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in Type II (non-insulin-dependent) diabetic subjects. Diabetologia 33:532-537
106. Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Esposito-del Puente A, Knowler WC, Ravussin E, Mott DM, Bennett PH 1989 Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 38:1423-1432
107. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Knowler WC, Bennett PH, Moll P, Bogardus C 1987 In vivo insulin action is familial characteristic in non-diabetic Pima Indians. Diabetes 36:1329-1335
108. Mahtani MM, Widén E, Lehto M, Thomas J, McCarty M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander E, Groop LC 1996 Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 13:90-94
109. Philippe J 1994 Pancreatic expression of the insulin and glucagon genes: update 1994. In: Underwood LE, Negro-Vilar A (eds) The Endocrine Pancreas, Insulin Action, and Diabetes. Endocrine Reviews Monographs, The Endocrine Society, Bethesda, MD, vol 2:21-27
110. Taylor SI, Wertheimer E, Accili D, Cama A, Hone J, Roach P, Quon MJ Suzuki Y, Levy-Toledano R, Taouis M, de la Luz Sierra M, Barbetti F, Gorden P 1994 Mutations in the insulin receptor gene: update 1994. In: Underwood LE, Negro-Vilar A (eds) The Endocrine Pancreas, Insulin Action, and Diabetes. Endocrine Reviews Monographs, The Endocrine Society, Bethesda, MD, vol 2:58-65
111. Cox NJ, Kun-San X, Fajans SS, Bell GI 1992 Mapping diabetes-susceptibility genes: lessons learned from search for DNA marker for maturity-onset diabetes of the young. Diabetes 41:401-407
112. Steiner DF, Tager HS, Nanjo K, Chan SJ, Rubenstein AH 1995 Familial syndromes of hyperproinsulinemia and hyperinsulinemia with muld diabetes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp 897-904
113. Maassen JA, Kadowaki T 1996 Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 39:375-382
114. Bell GI 1991 Molecular defects in diabetes mellitus. Diabetes 40: 413-422
115. King H, Rewers M 1993 Ad hoc Diabetes Reporting Group: global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177
116. Hales CN, Barker DJP 1992 Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35: 595-601
117. Hidaka H, Nagulesparan M, Klimes I, Clark A, Sasaki H, Aronoff SL, Vasquez B, Rubenstein AH, Unger RH 1982 Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetes mellitus. J Clin Endocrinol Metab 54:217-222
118. DeFronzo RA, Gunnarson R, Bjorkman O, Olsson M, Wahren J 1985 Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 76:149-155
119. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini B, Bier DM, Cobelli C, DeFronzo RA 1996 Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45: 915-925
120. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228
121. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI 1995 Decreased muscle glucose transport/ phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci 92:983-987
122. Gepts W, Lecompte PM 1981 The pancreatic islets in diabetes. Am J Med 70:105-14
123. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Molt DM, Bennett PH 1989 Sequential changes in serum insulin concentrations during development of non-insulin-dependent diabetes. Lancet 1:1356-1359
124. Rossetti L, Giaccari A, DeFronzo RA 1990 Glucose toxicity. Diabetes Care 13:610-630
125. Thompson DB, Janssen RC, Ossowski VM, Prochazka M, Knowler WC, Bogardus C 1995 Evidence for linkage between a region on chromosome Ip and the acute insulin response in Pima Indians. Diabetes 44:478-481
126. Westermark GT, Christmanson L, Terenghi G, Permerth J, Betsoltz C, Larsson J, Polak JM, Westermark P 1993 Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits. Diabetologia 36:323-328
127. Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbauer M, Woloszczuk W, Prager R 1991 Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 32:52-54
128. Mojsov S, Weir GC, Habener JF 1987 Insulinotropin: glucagon-like peptide 1 (7-37) coencoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619
129. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creuzfeld W 1993 Preserved incretin activity of glucagon-like peptide 1 (7-36)amide but not of synthetic human gastric inhibitory polypeptide in patients with type II diabetes mellitus. J Clin Invest 91:301-307
130. Dunning BE, Taborsky GJ 1988 Galanin-sympathetic neurotransmitter in endocrine pancreas. Diabetes 37:1157-1162
131. Phillips DIW 1996 Insulin resistance as a programmed response to fetal undernutrition. Diabetologia 39:1119-1122
132. DeFronzo RA 1997 Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269
133. Ferrannini E, Stern MP 1995 Primary insulin resistance: a risk syndrome. In: Leslie RDG, Robbins DC (eds), Diabetes: Clinical Science in Practice. Cambridge University Press, Cambridge, U.K., pp 200-220
134. Nabulsi AA, Folsom AR, Heiss G, Weir SS, Chambless LE, Watson RL, Eckfeldt JH 1995 Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean vs. obese subjects. Metabolism 44:914-922
135. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP 1992 Prospective analysis of the insulin resistance syndrome (Syndrome X). Diabetes 41:715-722
136. Wingard DL, Barrett-Connor E 1995 Heart disease and diabetes. In: Diabetes in America, ed. 2. NIH Publication No. 95-1468. National Institutes of Health, Bethesda, MD, pp. 429-448
137. Welborn TA, Wearne K 1979 Coronary disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-160
138. Pyöräla K 1979 Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-141
139. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G 1980 Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210
140. Despres J-P, B Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J 1996 Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957
141. Paolisso G, Gambardella A, Galzerano D, D'Amore A, Balbi V, Varricchio M, D'Onofrio F 1993 Metabolic features of patients with and without coronary heart disease but with a superimposable cluster of cardiovascular risk factors. Coron Artery Dis 4:1085-1091
142. Jarrett RJ 1994 Why is insulin not a risk for coronary heart disease? Diabetologia 37:945-947
143. Reaven GM, Laws A 1994 Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 37:948-952
144. Stern MP 1994 The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia 37:956-958
145. Tuomilehto-Wolf E, Tuomilehto J, Hitman GA, Nissinen A, Stengard J, Pekkanen J, Kivinen P, Kaarsalo E, Karvonen MJ 1993 Genetic susceptibility to non-insulin-dependent diabetes mellitus and glucose intolerance are located in HLA region. Br Med J 307: 155-159
146. Rurner RC, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R 1997 UKPDS 25: auto-antibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293
147. Mari A 1993 Circulatory models of intact-body kinetics and their relationship with compartmental and noncompartmental analysis. J Theor Biol 160:509-531
148. Avogaro A, Bristow JD, Bier DM, Cobelli C, Toffolo G 1989 Stable-label intravenous glucose tolerance test minimal model. Diabetes 38:1048-1055
149. Bouchard C 1992 Genetic aspects of obesity. In: Björntorp P, Brodoff BN (eds) Obesity. JB Lippincott Co., Philadelphia, pp 343-351
150. Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, Bogardus C 1991 Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866-876
151. Bjorntorp P 1988 Abdominal obesity and the development of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 4-615-622
152. Stokes J, Garrison RJ, Kannel WB 1985 The independent contribution of various indices of obesity on the 22-yr incidence of coronary artery disease: the Framingham Heart Study. In: Vague J, Björntorp P, Guy-Grand B, Rebuffé-Scrive M, Vague P (eds) Proceedings of the International Symposium on the Metabolic Complications of Human Obesities, Marseille, France. ICS No. 682. Elsevier, Amsterdam, pp 49-57
153. Chen K-W, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fujimoto WY 1995 Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 18:747-753
154. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH 1988 Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab 67:760-767
155. Head J, Fuller JH 1990 International variations in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 33:477-481
156. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M 1996 Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 19:1445-1448
157. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J 1993 A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16:996-1003
158. Xiang KS, Cox NJ, Sanz N, Huang P, Karan JH, Bell GI 1988 Insulin receptor and apolipoprotein genes contribute to development of NIDDM in Chinese Americans. Diabetes 38:17-23
159. Bilous RW, Marshall SM 1997 Clinical aspects of nephropathy. In: Alberts KGMM, Zimmet P, DeFronzo RA, Keen H (Honorary) (eds) International Textbook of Diabetes Mellitus. ed. 2. John Wiley & Sons Ltd, Chichester, U.K., vol 2:1362-1411
160. Barrett E, DeFronzo RA, Bevilacqua S, Ferrannini E 1982 Insulin resistance in diabetic ketoacidosis. Diabetes 31:923-929